Hemostatic implant

Patent metadata

Field	Value
Publication number	US-9889230-B2
Application number	US-93849110-A
Country	US
Kind code	B2
Filing date	Nov 3, 2010
Priority date	Oct 17, 2008
Publication date	Feb 13, 2018
Grant date	Feb 13, 2018

Abstract

The present disclosure relates to collagen-containing implants including a porous substrate having a first hydrogel precursor and a second hydrogel precursor applied thereto in a manner such that the first hydrogel precursor and second hydrogel precursor do not react with each other until the implant is placed at the site of implantation and exposed to the physiological fluids of a patient.

First claim

What is claimed is:

1. An implant comprising:
a porous substrate having a first hydrogel precursor comprising collagen applied to the porous substrate; and
a film containing a second hydrogel precursor formed of a water soluble polymer including polyethylene glycol, polyethylene oxide, polyethylene oxide-co-polypropylene oxide, co-polyethylene oxide block or random copolymers, polyvinyl alcohol, poly(vinyl pyrrolidinone), dextran, chitosan, alignates, carboxymethycellulose, oxidized cellulose, hydroxyethylcellulose, hyaluronic acid, or combinations thereof, the water soluble polymer functionalized to possess electrophilic groups, the film applied to the porous substrate,
wherein the first hydrogel precursor is spatially separated from the second hydrogel precursor, and the first hydrogel precursor is configured to react with the second hydrogel precursor upon contact with bodily fluid after implantation, thereby forming a hydrogel.

2. The implant of claim 1 , wherein the porous substrate is a foam.

3. The implant of claim 1 , wherein the porous substrate is a knitted textile.

4. The implant of claim 1 , wherein the porous substrate is a non-woven textile.

5. The implant of claim 1 , wherein the porous substrate is made from a bioabsorbable material.

6. The implant of claim 1 , wherein the porous substrate is made from a non-bioabsorbable material.

7. The implant of claim 1 , wherein the porous substrate is made from oxidized cellulose.

8. The implant of claim 1 , wherein the first hydrogel precursor comprises particles.

9. The implant of claim 1 , wherein the first hydrogel precursor further comprises at least one basic salt comprising borates, carbonates, phosphates, bicarbonates, and combinations thereof.

10. The implant of claim 1 , further comprising a bioactive agent.

11. An implant comprising:
a porous substrate having a first hydrogel precursor comprising collagen applied to a first portion of the porous substrate; and
a second hydrogel precursor formed of a water soluble polymer including polyethylene gylcol, polyethylene oxide, polyethylene oxide co-polypropylene oxide, co-polyethylene oxide block or random copolymers, polyvinyl alcohol, poly(vinyl pyrrolidinone), dextran, chitosan, alginates, carboxymethylcellulose, oxidized cellulose, hydroxyethylcellulose, hyaluronic acid, or combinations thereof, the water soluble polymer functionalized to possess electrophilic groups, the second hydrogel precursor applied to a second portion of the porous substrate,
wherein the first portion of the porous substrate is spatially separated from the second portion of the porous substrate, the first hydrogel precursor is spatially separated from the second hydrogel precursor, and the first hydrogel precursor is configured to react with the second hydrogel precursor upon contact with bodily fluid after implantation, thereby forming a hydrogel.

12. The implant of claim 11 , wherein the porous substrate is a foam.

13. The implant of claim 11 , wherein the porous substrate is a knitted textile.

14. The implant of claim 11 , wherein the porous substrate is a non-woven textile.

15. The implant of claim 11 , wherein the porous substrate is made from a bioabsorbable material.

16. The implant of claim 11 , wherein the porous substrate is made from a non-bioaborbable material.

17. The implant of claim 11 , wherein the porous substrate is made from oxidized cellulose.

18. The implant of claim 11 , wherein the first hydrogel precursor comprises particles.

19. The implant of claim 11 , wherein the second hydrogel precursor is a foam.

20. The implant of claim 11 , wherein the second hydrogel precursor is a film.

21. The implant of claim 11 , further comprising a bioactive agent.

22. The implant of claim 11 , wherein the first hydrogel precursor further comprises at least one basic salt comprising borates, carbonates, phosphates, bicarbonates, and combinations thereof.

23. The implant of claim 1 , wherein the second hydrogel precursor comprises a polyethylene glycol functionalized with N-hydroxysuccinimides.

24. The implant of claim 11 , wherein the second hydrogel precursor comprises a polyethylene glycol functionalized with N-hydroxysuccinimides.

Assignees

• Bennett Steven
• Sargeant Timothy
• Covidien Lp

Inventors

• Bennett Steven
• Sargeant Timothy

Classifications

• A61P17/02

  for treating wounds, ulcers, burns, scars, keloids, or the like · CPC title

• A61P19/00

  Drugs for skeletal disorders · CPC title

• A61L27/56

  Porous materials, {e.g. foams or sponges} · CPC title

• A61L27/48

  with macromolecular fillers · CPC title

• A61L27/34

  Macromolecular materials · CPC title